Compression dressing of the leg after Total Hip Arthroplasty leads to less blood loss

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00022569

Enrollment

1110

Registered

2021-02-08

Start date

2022-01-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip prosthestis implantation M16

Interventions

Group 1: THA with compression bandage Group 2: THA without compression bandage

Eligibility

Sex/Gender

All

Age

18 Years to 95 Years

Inclusion criteria

Inclusion criteria: age between 18 and 95, Hip arthrosis, planed primary hip arthroplasty, ability to give consent, ability to pass the aftercare

Exclusion criteria

Exclusion criteria: pregnancy, actual malignancy, Radioation or chemo-therapy 6 month before operation, heart failure NYHA 4, drug use, liver cirrhosis, inability to pass aftercare

Design outcomes

Primary

Measure	Time frame
postoperative blood loss calculated by Nadler- and Brecher-formula	—

Secondary

Measure	Time frame
postoperative rate of transfusion, woundhealing, complications of compression bandage, course of postoperative CrP and GFR, Hospitalisation time, operation time operative approach, kind of implant, fixations of implant, name of surgeon, leg circumference (10cm and 20cm proximal knee) pre-operative, second post-operative day and day of demission	—

Countries

Germany

Contacts

Public ContactSebastian Rohe

Waldkliniken Eisenberg GmbH

S.rohe@waldkliniken-eisenberg.de+493669181276

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026